SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SakuraBead Used as Resorbable Embolic for Plantar Fascia Embolization — Stella

Home/Plantar Fascitis/

View on ClinicalTrials.gov

Recruiting

Back to Plantar Fascitis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Uzbekistan

Nano Medical Clinic, Tashkent, Uzbekistan

Key details

Sponsor

CrannMed

Enrollment target

~45 participants

Started

October 2025

Primary completion

June 2026

Age range

18 Years – 75 Years

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.